INKT

MiNK Therapeutics, Inc. Common Stock
Data: 2026-01-30
$11.78
Price
-2.57%
Change
$76
52W High
$4.5601
52W Low

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Quick Stats
Jan 30, 2026

60.2

AI Score

BUY

1.47

Volume Ratio

Mar 17, 2026

Next Earnings

13

+ve Days (30d)

16

-ve Days (30d)

INKT Stock Summary

Last updated Jan 30, 2026

INKT is currently trading at $11.78, positioned below its 200-day moving average of $12.33, suggesting bearish momentum. The stock has a 52-week range of $4.5601 to $76.

Technical Analysis: The 50-day moving average stands at $11.8, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 44.447, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.074, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates INKT at 60.2/100 with a BUY recommendation.

INKT (MiNK Therapeutics, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 44.447
CMF (20) 0.074
ROC (10) -0.423
ADX (14) 9.853
Indicator Value
MACD (12,26,9) 0.072
AROONOSC (14) 57.143
WILLAMS %R (14) -69.14
MFI (14) 45.918
INKT Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

INKT Price vs Max Options Open Interest
INKT Max Change In Options Open Interest

INKT Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

INKT Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

INKT Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

INKT Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

MiNK Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

INKT Moving Averages Analysis

MiNK Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026

INKT (MiNK Therapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 12.32
20 12.16
30 12.03
50 11.8
100 13.06
200 12.33

INKT Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 57.5 million
Earnings/Share ($) -3.01
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -3.07
EPS Estimate Next Year ($) -3.89
WallStreet Target Price ($) 39
Most Recent Quarter